soilDBdata
soilDBdata exists so soilDB's tests can run without a NASIS connection.
A side-by-side editorial comparison of medsim and scTypeEval — release velocity, themes, recent moves, and the top alternatives to consider.
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
scTypeEval evaluates the consistency of single-cell cell type annotations without a ground-truth reference, using pseudobulk distances, Wasserstein distances and reciprocal classification as alternative dissimilarity strategies. It cleared Bioconductor's submission process on its first cycle, moving from a 0.99.30 pre-release in April 2026 to version 1.0.0 in the Bioconductor 3.23 release a month later. It accepts matrix, Seurat and SingleCellExperiment inputs.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
scTypeEval evaluates the consistency of single-cell cell type annotations without a ground-truth reference, using pseudobulk distances, Wasserstein distances and reciprocal classification as alternative dissimilarity strategies. It cleared Bioconductor's submission process on its first cycle, moving from a 0.99.30 pre-release in April 2026 to version 1.0.0 in the Bioconductor 3.23 release a month later. It accepts matrix, Seurat and SingleCellExperiment inputs.
The visible history is short and shaped entirely by the Bioconductor pipeline — the 0.99.x series is that project's submission convention, and 1.0.0 is what acceptance looks like rather than a maturity claim by the authors. What the pre-release notes emphasise is breadth of input format and of dissimilarity strategy rather than a single recommended method, which suggests the package is positioned as a comparison harness rather than a scoring tool. Nothing in these two entries indicates work beyond getting accepted.
With only a submission cycle in the record, there is not enough here to predict a direction; the next release will most likely be whatever the Bioconductor 3.24 cycle requires, and the first post-acceptance release is what will show whether development continues.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either medsim or scTypeEval.
soilDBdata exists so soilDB's tests can run without a NASIS connection.
collinear has broken its API twice to stop making the user pick thresholds.
nert put fourteen TERN datasets behind one dispatcher and called it stable.
medrobust made its partial-identification bounds usable by giving them confidence intervals.
probmed went from one probabilistic effect size to a family of them in sixteen days.
fluxnet keeps swapping its own plumbing — first a Python downloader, now a DuckDB backend.
See all medsim alternatives → · See all scTypeEval alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — r package — within Analytics. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.
Top scTypeEval alternatives in Analytics are ranked by recent ship velocity. Browse the "scTypeEval alternatives" section above for the current picks, or visit /alternatives/sctypeeval for the full list with editorial commentary on each.